Abhay Joshi Email Address

Chief Operating Officer, President of R and D and Product Operations

Revance is committed to the advancement of remarkable science that improves patient outcomes.

Dr. Abhay Joshi joined Revance as Chief Operating Officer in December 2015. Dr. Joshi has over thirty years of global experience as a pharmaceutical and biotechnology executive. From 2007 to 2015, he was the President and Chief Executive Officer of Alvine Pharmaceuticals, a privately held clinical stage company focused on the development of biologics targeting autoimmune and inflammatory diseases. He also served as an Executive Vice President and Chief Technical Officer at CoTherix, Inc., which was acquired by Actelion Ltd in 2007. Prior to CoTherix, Dr. Joshi was the Vice President of Global Technical Operations, Specialty Pharmaceuticals at Allergan, Inc. where he was responsible for the company’s global biologics manufacturing operations for BOTOX® and its Latin America and Asia Pacific pharmaceutical operations, and held a series of senior management positions. He serves on the Boards of Genyous Biomed, Sira Pharmaceuticals, and Sinopia Biosciences Inc. Dr. Joshi was inducted to the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows Class of 2016. Dr. Joshi received his B.Tech in Chemical Engineering from the Indian Institute of Technology (IIT), New Delhi, an M.S.E. and a Ph.D. in Chemical Engineering from the University of Michigan, Ann Arbor, and an M.B.A. from the University of California, Irvine.